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Abstract 
Purpose: To determine the benefits for patients who received an Electric 
Powered Indoor/outdoor Chair (EPIOC) and to quantify their perceived changes to 
their quality of life. 
 
Method: Community-based cohort study of all patients provided with an EPIOC 
over 4 months;  and followed up about 3 months later in a community served by a 
regional wheelchair service in North West London (population about 3.1 million) 
using the EuroQol EQ-5D with visual analogue scales for each of the 5 dimensions of 
the EQ-5D. 
 
Results: Sixty-four wheelchair users were assessed initially and 51 completed 
follow up. Chair users showed no significant improvement in health state as measured 
by the EQ-5D after EPIOC provision. The visual analogue scales (VASs) indicated 
that, although perceived overall health state, independence and social life did not 
appear to improve, the dimensions of mobility, quality of life and pain/discomfort 
improved significantly on provision of an EPIOC. 
 
Conclusion: EPIOC users reported significant improvements in several important 
aspects of their lives; not just in mobility (as expected) but also in reduction of pain 
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and discomfort. The use of VASs provided a more holistic set of outcome measures 
that demonstrate quality of life benefits beyond that of health state alone.  
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Introduction 
Electric Indoor/Outdoor Powered Wheelchairs (EPIOCs) are only available in the UK 
for very severely disabled individuals 1. In 1997, a service was set up for the 
introduction of EPIOC chairs in the North West London Region 2. Initial assessments 
by our service 2,3 and others 4-6 have suggested that these chairs may improve the 
quality of life for those who use them (the users).  
 
Few studies have been performed that have aimed to demonstrate the benefit to users 
of EPIOC provision. None to our knowledge have tested the assumption that quality of 
life is significantly improved after EPIOC provision. Consequently we have tested this 
assumption in our cohort using their self-assessed quality of life before and after 
provision. 
 
Quality of life issues are recognised as being important for wheelchair services 7, have 
been reported anecdotally 5 and are considered to be important by the users.  
Initial audit has indicated that EPIOC users are a heterogeneous group 3 . Generic 
quality of life measures are likely to be the most appropriate. However the SF36 has 
been reported as being problematic in a similar group of severely disabled individuals 
8 
 and the EuroQol EQ-5D (EQ-5D) 9 has been found to lack discrimination in highly 
disabled populations 10. However, other domains such as ‘vitality’ and ‘bodily pain’ 
showed no such effect. Thus there is a continued need to test other instruments in such 
populations 8.  
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The EQ-5D 9 is a widely used quality of life measure. It is short and easy to administer 
11 
 and is designed to be appropriate when used as part of a face-to-face interview. The 
instrument consists of five dimensions with three levels of response for each in the 
form of a statement, and a visual analogue scale (VAS) on which respondents are 
asked to indicate how good or bad their health state is on the day of response. The aim 
of this study is to assess the change in quality of life after provision of an EPIOC using 
the EQ-5D. 
 
Subjects 
All potential users (n= 72) who were assessed as suitable for EPIOC provision by the 
Regional EPIOC Service between November 1998 and February 1999 were 
approached to participate irrespective of age, sex or diagnosis. Initial contact was 
made by telephone. Three people could not be contacted, three people declined to 
participate, one person was not interviewed due to wheelchair delivery being brought 
forward and one person failed to keep the appointment. Thus 64 users entered the 
study (28 male, 36 female; mean age 52 sd 21 years, range 14-83). Their main 
diagnoses are given in table 1.  
 
[Insert table 1 about here] 
 
Methods 
The EQ-5D was presented as part of a face-to-face interview as some users were 
unable to write.  All users were offered the option of marking their own responses or 
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having them marked on their behalf according to their instructions whilst 
simultaneously viewing the process. In almost all cases this latter option was chosen.  
 
Subjects completed the five dimensions of the EQ-5D, each with three levels of 
response, and a single VAS. The mobility dimension asks respondents to indicate their 
current mobility by ticking the most appropriate of three statements, ‘I have no 
problems in walking about’, ‘I have some problems in walking about’, or ‘I am 
confined to bed’. In an EPIOC user population, any reference to ‘walking’ is 
inappropriate. Face validity is compromised. Thus the mobility dimension of the EQ-
5D was modified to present the response statements as ‘I am able to walk a few steps’, 
‘I am able to transfer only’ or ‘I am not able to walk at all’. Users were also asked to 
complete five additional VASs in a thermometer style. These were for mobility, 
independence, social life, quality of life, and pain/discomfort, the same dimensions as 
used by the EQ-5D. 
 
The assessment, including the VASs, was completed in accordance with the 
instructions in the EuroQol Users Guide 12. The assessor was independent of the 
EPIOC service and the assessments were not available to any of the service providers. 
 
Initial and follow-up interviews were conducted by appointment within the user’s 
home or residential college. This allowed the users to respond to questions in familiar 
and relaxing surroundings and ensured that the interview context remained consistent. 
Interviews were conducted over nine months, during which time 51 patients received 
their EPIOC. The mean time to follow up interview was 97 (sd 16) days. At the follow 
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up assessment, users were asked to provide ratings on the current VASs compared to 
their baseline ratings. Thus, a relative opinion was required. 
 
Methods of analysis  
The EQ-5D was scored using a table of pre-determined values from the user guide 12. 
Visual analogue scores obtained prior to EPIOC delivery (Pre-EPIOC) were compared 
with those scores obtained from the same respondents at follow-up (Post-EPIOC). The 
Wilcoxon Matched-Pairs Signed Ranks test (two-tailed), with Bonferroni corrections, 
was used to determine significant differences between pre and post-EPIOC conditions. 
Data sets were analysed using SPSS 8.0 for Windows.  
 
Results 
Fifty-one people (table 1) received chairs during the study period and completed both 
assessments. The before and after mean scores of the EQ-5D were 0.098 (sd 0.25) and 
0.119 (sd 0.29) respectively. As expected in a group of severely disabled subjects, no 
significant differences were found and no significant differences were found for any of 
the subsections either (data not shown). 
 
EPIOC users were asked to rate their own health state using the VAS in the EQ-5D 
prior to and after EPIOC delivery.  Two subjects were unable to conceptualise their 
condition using this method and therefore did not provide a response. The mean 
estimated health ratings for the 49 subjects were 56.9 (sd 21.9) at baseline and 55.7 (sd 
24.2). No significant difference was found for the ‘health’ dimension. Neither were 
there significant findings for the VAS responses in the dimensions of social life and 
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independence. However there were significant improvements for the VAS responses in 
the dimensions of ‘pain/discomfort’, ‘mobility’ and ‘quality of life’ (table 2).  
 
[Insert table 2 about here] 
 
Discussion 
Lack of EPIOC service research 
Recognising that the field of EPIOC provision in the UK has not been researched 
adequately 3 , the lack of data on patients’ experiences is even more dramatic. Our 
searches have only revealed few publications incorporating EPIOC users’ views on 
their experiences 5,6 . To our knowledge no previous study has attempted prospectively 
to assess changes in the quality of life after EPIOC provision.  The Edinburgh study 
examined user handicap before and after provision, but limited the study to the use of 
instruments rather than eliciting user views 4. The Department of Health evaluation 
performed by the University of York was a retrospective survey, although large 
numbers were reported 6. 
 
Sample 
Although the study sample was modest, the range of diagnoses was not different 
proportionately to our previous study 3 , although the mean group age (53) was 
somewhat higher. At least a third had progressive conditions, e.g. multiple sclerosis 
and muscular dystrophy (table 1) and their health would be likely to deteriorate over 
time. Sampling from community registers might give a broader range of disability 8,13. 
However, samples also appear to vary across centres for EPIOC provision 14. Some of 
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these users would have been previous EPIOC users, and would not be expected to 
have any improvement in their quality of life3. 
 
Quality of life 
The results from the adjusted EQ-5D for EPIOC users showed that the instrument may 
have limited value in detecting change in the perceived quality of life of such severely 
physically disabled people. It may also be that generic quality of life scales may have 
limited value in evaluating specific health service interventions 15, such as EPIOCs. 
Our results showed that the EQ-5D was too blunt an instrument to detect improved 
quality of life in severely disabled wheelchair-users. A similar finding was observed 
with those with rheumatic disorders using the EQ-5D 11 and with the SF36 8,16.  
 
The VASs on the other hand supported findings previously reported anecdotally  2,3. 
There has been a suggestion that VAS use is more helpful in identifying lesser changes 
than the broad EQ-5D categories as a VAS has non-restricted scaling 11. Therefore, it 
appears that the VASs allow the user more freedom to report changes according to 
their own views.  
 
Quality of life is considered to be a complex concept including not only health and 
disability dimensions, but also the wider social and psychological dimensions 17. In 
order to maintain respondents’ own perceptions, interpretation of the meaning of each 
dimension was not imposed, and respondents were free to interpret each in their own 
terms and they could respond using their own individual value system for ‘quality of 
life’. Therefore users self-assessment using visual analogue scales could have provided 
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the opportunity for a more holistic assessment of this complex concept on an 
individual basis. This contrasts with the pre-defined dimensions of the EQ-5D, each 
with a specific field of response. Within the EQ-5D user guide 12 the problem of 
limited statements is recognised. 
 
There is no evidence to suggest that a person may not be both ‘healthy’ and disabled 
simultaneously. A small improvement of mean health state for recipients was 
suggested after receiving an EPIOC when the EQ-5D was used. This was unexpected 
in view of the progressive nature of some users’ conditions.  
 
Although the level of ability to perform activities may be unaffected by the 
introduction of an EPIOC, the range of activities may change following this 
intervention. Therefore the ability to perform new activities after intervention is a 
greater indication of benefit than performance levels on existing activities. This aspect 
of improvement will not be elicited by the EQ-5D, but could well enter the more 
holistic self-assessment obtained by the VASs. 
 
The finding that pain and discomfort was significantly reduced after EPIOC provision 
is important. A previous survey has reported that 26% of EPIOC users complain of 
discomfort 3 but when followed up 1.9 years after provision this figure had risen to  
46% 18. This dimension of pain and discomfort posed problems in that people 
experienced difficulty in commenting on levels of pain or discomfort in the categories 
of ‘none’, ‘moderate’ and ‘extreme’.  Pain intensity is known to be difficult to quantify 
and individuals indicated that their levels of pain fluctuated many times within a single 
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day 19.  To some extent this difficulty was addressed by the introduction of a VAS that 
required users to indicate their perceived level of pain or discomfort ‘when using their 
wheelchair’. These findings confirm those of Samuelsson et al 20 who reported 
reduction in seating discomfort and back pain using VAS following wheelchair 
intervention.  
 
Despite some users having a previous powered chair 3, the group as a whole reported 
significant improvements in mobility. However, no significant improvements were 
noted in ‘independence’ or in ‘social life’. It may be that changes in independence and 
social life need more time to be established in the lives of users, while mobility is an 
immediate positive benefit of provision of an EPIOC. A longer follow up period may 
elucidate this further. Alternatively, the users may have perceived ‘independence’ as 
activities of daily living which would not be affected by EPIOC provision. 
 
This study supports the view that the EQ-5D could potentially be developed in this 
way. Further research on the use of the VASs, each representing one of the EQ-5D 
dimensions, is indicated.   
 
Limitations of the study 
One main limitation to this study was that the study group was heterogeneous. 
However the provision of an EPIOC is determined by the severity of disability rather 
than any specific diagnosis. It is our observation, however, that some groups of users 
e.g. those with Muscular Dystrophy require more complex chair prescriptions and 
change more rapidly than some other groups e.g. cerebrovascular disease. Larger 
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groups of users will need to be studied before differences between diagnostic groups 
can be identified.  
 
The mean duration of time from provision of chair to assessment was only about three 
months. As many users require modification to their chairs, which can take time, some 
users may not have acquired maximum benefit from their chair at the time of follow 
up. A longer follow-up period to allow users to practice with their new chairs is 
indicated. 
 
Conclusion: 
The introduction of an EPIOC into wheelchair-users lives has not significantly altered 
their perceived health state. It has, however significantly improved their perception of 
several important aspects of their lives. These were reduced pain and discomfort, and   
improved levels of mobility and perceived quality of life. Extension to the EQ-5D 
using visual analogue scales has provided a more holistic set of outcome measures that 
demonstrate quality of life benefits beyond that of health state alone.  
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Table 1 
 
 
Main diagnosis of the study group 
 
 
 
Diagnoses:  Interviewed 
prior to 
receiving 
EPIOC (n=64) 
Interviewed 
prior to and 
following receipt 
of EPIOC (n=51) 
Multiple sclerosis  10  9  
Muscular dystrophy  8  6  
Other neurological  8  6  
Cerebral palsy  8  5  
Spinal cord injury  8  4  
Cerebrovascular 
disease 
 
6  6  
Musculoskeletal  5  5  
Mixed disabilities  3  3  
Rheumatoid arthritis  3  2  
Polio  2  2  
Miscellaneous/other  3  3  
Age:  mean   52 
sd        21 
mean   54 
sd        21 
Sex:      Male   28  23  
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Table 2 
 
Visual analogue scores for 49 EPIOC users before and after provision. 
 
 
 
 Pre-
EPIOC 
Post-
EPIOC 
p values 
Health 56.9 (21.9) 55.7 (24.2) NS 
Mobility 35.3 (27.7) 54.8 (28.9)  0.001 
Pain/discomfort 45.0 (32.7) 27.1 (29.1)  0.001 
Social life 44.4 (28.9) 51.8 (25.6)  NS 
Independence 34.3 (28.9) 44.0 (28.1)  NS 
Quality of life 53.7 (27.2) 63.8 (26.2)  0.02 
 
